BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 21996205)

  • 41. BK viremia and nephropathy in pediatric renal transplant recipients.
    Hamasaki Y; Dolan NM; Cubitt D; Breuer J; Sebire NJ; Marks SD
    Pediatr Transplant; 2019 Aug; 23(5):e13460. PubMed ID: 31273924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of BK viruria on the long term graft survival in renal transplant recipients].
    Huang G; Wang C; Huang Y; Luo X; Fei J; Deng S; Li J; Chen G; Fu Q; Deng R; Qiu J; Chen L
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2771-4. PubMed ID: 26711975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for BK virus infection in the era of therapeutic drug monitoring.
    Borni-Duval C; Caillard S; Olagne J; Perrin P; Braun-Parvez L; Heibel F; Moulin B
    Transplantation; 2013 Jun; 95(12):1498-505. PubMed ID: 23778568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.
    Elfadawy N; Flechner SM; Liu X; Schold J; Tian D; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Transpl Int; 2013 Aug; 26(8):822-32. PubMed ID: 23763289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipients.
    Girmanova E; Brabcova I; Bandur S; Hribova P; Skibova J; Viklicky O
    J Med Virol; 2011 Aug; 83(8):1395-400. PubMed ID: 21618550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients.
    Randhawa P; Ho A; Shapiro R; Vats A; Swalsky P; Finkelstein S; Uhrmacher J; Weck K
    J Clin Microbiol; 2004 Mar; 42(3):1176-80. PubMed ID: 15004071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients.
    Puliyanda DP; Toyoda M; Traum AZ; Flores FX; Jordan S; Moudgil A; Somers MJ
    Pediatr Transplant; 2008 Mar; 12(2):180-6. PubMed ID: 18307666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Frequency and Associated Factors for BK Virus Infection in a Center Performing Mainly Living Kidney Transplantations.
    Alagoz S; Kuskucu M; Gulcicek S; Yalin SF; Oruc M; Midilli K; Yılmaz E; Altiparmak MR; Seyahi N
    Prog Transplant; 2017 Jun; 27(2):152-159. PubMed ID: 28617169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation.
    Steubl D; Baumann M; Schuster T; Fischereder M; Krämer BK; Heemann U; Lutz J
    Scand J Urol Nephrol; 2012 Dec; 46(6):466-74. PubMed ID: 23016678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of BK Virus in Renal Transplant at a Single Center: Experience With Our Ureteral Reimplantation Surgical Technique.
    Martínez Moreno AI; Guimerà Garcia J; Riera Mari V; Pieras Ayala E
    Exp Clin Transplant; 2020 Aug; 18(4):458-462. PubMed ID: 32490761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.
    Sood P; Senanayake S; Sujeet K; Medipalli R; Zhu YR; Johnson CP; Hariharan S
    Transplantation; 2012 Oct; 94(8):814-21. PubMed ID: 23018881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.
    van Doesum WB; Gard L; Bemelman FJ; de Fijter JW; Homan van der Heide JJ; Niesters HG; van Son WJ; Stegeman CA; Groen H; Riezebos-Brilman A; Sanders JSF
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28258601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches.
    Ginevri F; De Santis R; Comoli P; Pastorino N; Rossi C; Botti G; Fontana I; Nocera A; Cardillo M; Ciardi MR; Locatelli F; Maccario R; Perfumo F; Azzi A
    Transplantation; 2003 Apr; 75(8):1266-70. PubMed ID: 12717214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of BK virus infection in end-stage renal disease patients waiting for kidney transplantation--viral replication dynamics from pre- to post-transplant.
    Mitterhofer AP; Tinti F; Pietropaolo V; Umbro I; Anzivino E; Bellizzi A; Zavatto A; Poli L; Berloco PB; Taliani G
    Clin Transplant; 2014 Mar; 28(3):299-306. PubMed ID: 24506672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Characteristic and Outcomes of BK Virus Infection in Kidney Transplant Recipients Managed Using a Systematic Surveillance and Treatment Strategy.
    Lee S; Lee KW; Kim SJ; Park JB
    Transplant Proc; 2020; 52(6):1749-1756. PubMed ID: 32402452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction.
    Barton TD; Blumberg EA; Doyle A; Ahya VN; Ferrenberg JM; Brozena SC; Limaye AP
    Transpl Infect Dis; 2006 Jun; 8(2):102-7. PubMed ID: 16734633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
    Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
    Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence, Risk Factors, Treatment, and Overall Impact of BK Viremia on Kidney Transplantation.
    Malik O; Saleh S; Suleiman B; Ashqar B; Maibam A; Yaseen M; Elrefaei A; Hines A; Cornea V; El-Husseini A; Mei X; Gedaly R; Castellanos AL; Waid T
    Transplant Proc; 2019; 51(6):1801-1809. PubMed ID: 31399166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monthly screening for polyoma virus eliminates BK nephropathy and preserves renal function.
    Petrov R; Elbahloul O; Gallichio MH; Stellrecht K; Conti DJ
    Surg Infect (Larchmt); 2009 Feb; 10(1):85-90. PubMed ID: 19298172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
    Gabardi S; Townsend K; Martin ST; Chandraker A
    Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.